Laboratorios Farmaceuticos Rovi, S.A. (LON: 0ILL)
London
· Delayed Price · Currency is GBP · Price in EUR
61.65
+0.25 (0.41%)
Dec 23, 2024, 5:51 PM BST
Laboratorios Farmaceuticos Rovi Revenue
Laboratorios Farmaceuticos Rovi had revenue of 235.28M EUR in the quarter ending September 30, 2024, with 9.93% growth. This brings the company's revenue in the last twelve months to 799.25M, down -4.52% year-over-year. In the year 2023, Laboratorios Farmaceuticos Rovi had annual revenue of 829.51M with 1.44% growth.
Revenue (ttm)
799.25M EUR
Revenue Growth
-4.52%
P/S Ratio
n/a
Revenue / Employee
378.61K EUR
Employees
2,111
Market Cap
2.62B GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 829.51M | 11.81M | 1.44% |
Dec 31, 2022 | 817.70M | 169.02M | 26.06% |
Dec 31, 2021 | 648.68M | 228.72M | 54.46% |
Dec 31, 2020 | 419.96M | 38.65M | 10.14% |
Dec 31, 2019 | 381.31M | 78.11M | 25.76% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca PLC | 38.20B |
GSK plc | 31.31B |
Haleon plc | 11.24B |
Smith & Nephew plc | 4.46B |
ConvaTec Group PLC | 1.74B |
Hikma Pharmaceuticals PLC | 2.39B |
Oxford Nanopore Technologies plc | 167.75M |
Animalcare Group plc | 76.10M |